The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...
Infliximab Remicaid® Chimeric monoclonal antibody iv. infusion, 3 mg/kg at 0, 2 and 6 weeks followed by maintenance every 4–8 weeks Golimumab Simponi® Human monoclonal antibody sc. injection ...